Presented by:
Jay M. Tenenbaum, Chairman, CEO and Chief Scientist, CollabRx
Overview: Cancer Commons is an open science initiative where physicians, scientists, and patients collaborate on individualizing treatments.
Its goals are to:
1) give each patient the best possible outcome by personalizing therapy based on his or her tumor's genomic subtype,
2) learn as much as possible from each patient's response, and
3) rapidly disseminate what is learned.
Cancer Commons provides patient communities with personalized, actionable information that can save lives, while providing the life sciences industry with a game-changing infrastructure that will slash the time and cost of developing new drugs and diagnostics and getting them to patients.
